Radioembolization Complicated by Nontarget Embolization to the Falciform Artery

ABSTRACT

The most common application of radioembolization is in the treatment of primary and secondary liver tumors, and the most common radioisotope is Yttrium-90. This form of treatment has proven to be successful in achieving reduction of tumor size and ultimately improving survival. Fatigue and nausea/vomiting are the most common side effects related to radioembolization and are usually self-limiting. This report describes a case of abdominal pain caused by shunting of yttrium-90 microspheres to the anterior abdominal wall via a patent hepatic falciform artery. This case highlights the need for vigilant angiography and awareness of the falciform artery with prophylactic embolization when necessary/warranted.

KEYWORDS

Radioembolization - yttrium-90 - falciform artery

REFERENCES

• 1 Jemal A, Murray T, Ward E et al.. Cancer statistics, 2005.  CA Cancer J Clin. 2005;  55 (1) 10-30
• 2 Iñarrairaegui M, Bilbao J I, Rodríguez M, Benito A, Sangro B. Liver radioembolization using 90 y resin microspheres in elderly patients: tolerance and outcome.  Hosp Pract (Minneap). 2010;  38 (5) 103-109
• 3 Fong Y, Fortner J, Sun R L, Brennan M F, Blumgart L H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.  Ann Surg. 1999;  230 (3) 309-318, discussion 318–321
• 4 Choti M A, Sitzmann J V, Tiburi M F et al.. Trends in long-term survival following liver resection for hepatic colorectal metastases.  Ann Surg. 2002;  235 (6) 759-766
• 5 Khodjibekova M, Szyszko T, Khan S, Nijran K, Tait P, Al-Nahhas A. Selective internal radiation therapy with Yttrium-90 for unresectable liver tumours.  Rev Recent Clin Trials. 2007;  2 (3) 212-216
• 6 Salem R, Lewandowski R J, Mulcahy M F et al.. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.  Gastroenterology. 2010;  138 (1) 52-64
• 7 Leong Q M, Lai H K, Lo R G, Teo T K, Goh A, Chow P K. Radiation dermatitis following radioembolization for hepatocellular carcinoma: a case for prophylactic embolization of a patent falciform artery.  J Vasc Interv Radiol. 2009;  20 (6) 833-836
• 8 Williams D M, Cho K J, Ensminger W D, Ziessman H A, Gyves J W. Hepatic falciform artery: anatomy, angiographic appearance, and clinical significance.  Radiology. 1985;  156 (2) 339-340
• 9 Song S Y, Chung J W, Lim H G, Park J H. Nonhepatic arteries originating from the hepatic arteries: angiographic analysis in 250 patients.  J Vasc Interv Radiol. 2006;  17 (3) 461-469
• 10 Gibo M, Hasuo K, Inoue A, Miura N, Murata S. Hepatic falciform artery: angiographic observations and significance.  Abdom Imaging. 2001;  26 (5) 515-519
• 11 Kanzaki H, Nouso K, Miyahara K et al.. A case of hepatocellular carcinoma with skin injury of the upper abdominal wall after transcatheter arterial chemoembolization: a case report.  Cases J. 2009;  2 7197
• 12 Michels N A. Collateral arterial pathways to the liver after ligation of the hepatic artery and removal of the celiac axis.  Cancer. 1953;  6 (4) 708-724
• 13 Liu D M, Salem R, Bui J T et al.. Angiographic considerations in patients undergoing liver-directed therapy.  J Vasc Interv Radiol. 2005;  16 (7) 911-935